SEP 8, 2026 · PHASE 2 TRIAL
Study of ExAblate Focused Ultrasound Ablation of Breast Cancer
ClinicalTrials.gov
Phase 2, single-arm, non-randomized registry record with no results posted; describes planned safety and histopathological assessment in a small cohort without comparator or outcome data.
Reported
Sample size14
PhasePhase 2
Primary outcome measure 1Adverse Events, 5 weeks post treatment